Publications by authors named "Caroline Pressacco Brossier"
Article Synopsis
- Letermovir is used for preventing cytomegalovirus (CMV) in patients who have received hematopoietic stem cell transplants (HSCT), and its therapeutic drug monitoring (TDM) was studied for effectiveness and practicality.
- A study involving 40 adult patients found that letermovir levels in the blood remained stable for 70 days after treatment, but there was significant variability among patients.
- The presence of certain medications, such as posaconazole and cyclosporine, increased letermovir levels, while no clear links were found between these levels and the incidence of breakthrough CMV infections.
Populations of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae are different in human-polluted environment and food items: a multicentre European study.
Daniel Martak Julia Guther Tess D Verschuuren Benoit Valot Nadine Conzelmann Caroline Pressacco Brossier
Clin Microbiol Infect
March 2022
Objectives: To assess the extent to which food items are a source of extended-spectrum β-lactamase (ESBL) -producing Escherichia coli (ESBL-Ec) and ESBL-producing Klebsiella pneumoniae (ESBL-Kp) for humans in five European cities.
Methods: We sampled 122 human polluted (hp)-environments (sewers and polluted rivers, as a proxy of human contamination) and 714 food items in Besançon (France), Geneva (Switzerland), Sevilla (Spain), Tübingen (Germany) and Utrecht (The Netherlands). A total of 254 ESBL-Ec and 39 ESBL-Kp isolates were cultured.